Rennova Health, Inc.
RNVA
RNVA was delisted on the 24th of October, 2017.
3 hedge funds and large institutions have $218K invested in Rennova Health, Inc. in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
25% less funds holding
Funds holding: 4 → 3 (-1)
29% less capital invested
Capital invested by funds: $309K → $218K (-$91K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$16.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FNYS
First New York Securities
New York
|
-$123K |
| 2 |
U
UBS
Zurich,
Switzerland
|
-$16.9K |
RNVA Hedge Fund Activity: Q3 2013 in Review
3 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Rennova Health, Inc. (RNVA) for Q3 2013, worth a combined $218K — down 29% from $309K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of RNVA and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $16.9K. The largest seller was First New York Securities, exiting entirely with an estimated $123K sold.
- 3 institutional investors held Rennova Health, Inc. (RNVA) as of Q3 2013, down from 4 in Q2 2013.
- Funds reported $218K of Rennova Health, Inc. stock for Q3 2013, down 29% quarter-over-quarter.
- 1 fund opened new Rennova Health, Inc. positions in Q3 2013 and 2 closed out, a net change of -1 holder.
- The largest Rennova Health, Inc. buyer in Q3 2013 was Tower Research Capital (TRC), an estimated $16.9K added.
- The largest Rennova Health, Inc. seller in Q3 2013 was First New York Securities, an estimated $123K sold.
Based on aggregated 13F filings for Q3 2013.